FDA Inspection
Wuxi Biologics Co LtdWuxi Biologics Co Ltd – FDA Inspection, Jul 3, 2026
Record Details
This FDA Inspection record concerns Wuxi Biologics Co Ltd, with an inspection on July 3, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · c04aede4-d5ca-4740-8022-843a33a15ca2
Inspection Facts
- Inspection number
- 1324932
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Wuxi Biologics Co Ltd
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2024 | Not classified | Office of Inspections and Investigations | |
| May 9, 2023 | Not classified | Office of Inspections and Investigations | |
| April 2, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 16, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 2, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Wuxi Biologics Co Ltd
- FDA Inspection 1274331 - 2024-06-04
- FDA Inspection 1219694 - 2023-05-09
- FDA Inspection 1137612 - 2021-04-02
- FDA Inspection 1086695 - 2019-04-16
- FDA Inspection 1028829 - 2017-08-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.